Key statistics
On Friday, Armata Pharmaceuticals Inc (TG1N:FRA) closed at 1.92, 8.47% above its 52-week low of 1.77, set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.92 |
---|---|
High | 1.92 |
Low | 1.92 |
Bid | 2.12 |
Offer | 2.24 |
Previous close | 1.85 |
Average volume | 392.60 |
---|---|
Shares outstanding | 36.18m |
Free float | 10.77m |
P/E (TTM) | -- |
Market cap | 81.41m USD |
EPS (TTM) | -1.24 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Press releases
- Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting
- Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update
- Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia
- Armata Pharmaceuticals Announces Structural Biology Publication
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium
More ▼